Skip to main content
Lior Braunstein, MD, Radiation Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

LiorZ.BraunsteinMD

Radiation Oncology New York, NY

Radiation Oncologist, Memorial Sloan Kettering Cancer Center

Overview of Dr. Braunstein

Dr. Lior Braunstein is a radiation oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Bergen. He received his medical degree from Harvard Medical School and has been in practice 6 years. He is one of 103 doctors at Memorial Sloan Kettering Cancer Center and one of 6 doctors at Memorial Sloan Kettering Bergen who specialize in Radiation Oncology. He has more than 80 publications and over 500 citings.

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2012 - 2016
  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2011 - 2015
  • Brigham and Women's Hospital
    Brigham and Women's HospitalInternship, Internal Medicine, 2011 - 2012
  • Harvard Medical School
    Harvard Medical SchoolClass of 2011

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2023 - Present
  • NY State Medical License
    NY State Medical License 2016 - 2026
  • NJ State Medical License
    NJ State Medical License 2016 - 2025
  • MA State Medical License
    MA State Medical License 2013 - 2018
  • American Board of Radiology Radiation Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Accuracy of Magnetic Resonance Imaging–Guided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant Chemotherapy  
    Elizabeth J Sutton, Lior Z Braunstein, Yolanda Bryce, Jill S Gluskin, Pedram Razavi, JAMA Network Open
  • Potential Morbidity Reduction with Proton Radiation Therapy for Breast Cancer☆  
    Oren Cahlon, Lior Z Braunstein, ScienceDirect

Press Mentions

  • Mutations in BRCA1 and BRCA2 Differentially Affect the Tumor Microenvironment and Response to Checkpoint Blockade Immunotherapy
    Mutations in BRCA1 and BRCA2 Differentially Affect the Tumor Microenvironment and Response to Checkpoint Blockade ImmunotherapyNovember 16th, 2020
  • Cancer Therapy Shapes the Fitness Landscape of Clonal Hematopoiesis
    Cancer Therapy Shapes the Fitness Landscape of Clonal HematopoiesisOctober 26th, 2020
  • A Machine Learning Model That Classifies Breast Cancer Pathologic Complete Response on MRI Post-Neoadjuvant Chemotherapy
    A Machine Learning Model That Classifies Breast Cancer Pathologic Complete Response on MRI Post-Neoadjuvant ChemotherapyMay 28th, 2020
  • Join now to see all

Professional Memberships

Hospital Affiliations